Efficacy and safety of agomelatine given orally in children and adolescents with major depressive disorder: a randomized controlled trial

被引：0
|
作者：
Olivier, V. [1 ]
Marx, U. [2 ]
Picarel-Blanchot, F. [3 ]
Penelaud, P. F. [1 ]
De Bodinat, C. [1 ]
Falissard, B. [4 ]
机构：
[1] Ctr Therapeut Innovat, Inst Rech Int Servier, 50 Rue Carnot, F-92284 Suresnes, France
[2] Entwicklung GmbH, SERVIER Forsch & Pharma, Elsenheimerstr 53, D-80687 Munich, Germany
[3] Serv Med Affairs Internal Med & Neuropsychiat, Suresnes, France
[4] INSERM, U1018, Ctr Rech Epidemiol & Sante Populat Maison Solenn, CESP, 97 Bld Port Royal, F-75679 Paris 14, France
来源：
EUROPEAN NEUROPSYCHOPHARMACOLOGY | 2020年 / 40卷
关键词：
D O I：
10.1016/j.euroneuro.2020.09.244
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
P.322
引用
收藏
页码：S186 / S187
页数：2
相关论文
共 50 条
  • [1] Efficacy and Safety of Curcumin in Major Depressive Disorder: A Randomized Controlled Trial
    Sanmukhani, Jayesh
    Satodia, Vimal
    Trivedi, Jaladhi
    Patel, Tejas
    Tiwari, Deepak
    Panchal, Bharat
    Goel, Ajay
    Tripathi, Chandra Bhanu
    [J]. PHYTOTHERAPY RESEARCH, 2014, 28 (04) : 579 - 585
  • [2] Efficacy and Safety of Agomelatine in the Treatment of Major Depressive Disorder A Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial
    Zajecka, John
    Schatzberg, Alan
    Stahl, Stephen
    Shah, Amy
    Caputo, Angelika
    Post, Anke
    [J]. JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY, 2010, 30 (02) : 135 - 144
  • [3] Safety and efficacy of agomelatine in children and adolescents with major depressive disorder receiving psychosocial counselling: a double-blind, randomised, controlled, phase 3 trial in nine countries
    Arango, Celso
    Buitelaar, Jan K.
    Fegert, Jorg M.
    Olivier, Valerie
    Penelaud, Pierre-Francois
    Marx, Ute
    Chimits, Damien
    Falissard, Bruno
    [J]. LANCET PSYCHIATRY, 2022, 9 (02): : 113 - 124
  • [4] Efficacy of sertraline in the treatment of children and adolescents with major depressive disorder - Two randomized controlled trials
    Wagner, KD
    Ambrosini, P
    Rynn, M
    Wohlberg, C
    Yang, RY
    Greenbaum, MS
    Childress, A
    Donnelly, C
    Deas, D
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2003, 290 (08): : 1033 - 1041
  • [5] Efficacy and safety of add-on sarcosine in patients with major depressive disorder: A randomized controlled trial
    Padhan, Milan
    Mohapatra, Debadatta
    Mishra, Biswa Ranjan
    Maiti, Rituparna
    Jena, Monalisa
    [J]. JOURNAL OF PSYCHIATRIC RESEARCH, 2024, 178 : 298 - 304
  • [6] EFFICACY AND SAFETY OF AGOMELATINE IN TREATMENT OF MAJOR DEPRESSIVE DISORDER: A PILOT STUDY
    Nukala, Srikrishna
    Komaram, Ravi Babu
    Palla, Jayasree
    Murthy, K. S. N.
    [J]. INTERNATIONAL JOURNAL OF PHARMACEUTICAL SCIENCES AND RESEARCH, 2016, 7 (08): : 3517 - 3521
  • [7] A Comparative Study of Efficacy and Safety of Agomelatine and Escitalopram in Major Depressive Disorder
    Komaram, Ravi Babu
    Nukala, Srikrishna
    Palla, Jayasree
    Nambaru, Lakshmana Rao
    Kasturi, Satyanarayana Murthy
    [J]. JOURNAL OF CLINICAL AND DIAGNOSTIC RESEARCH, 2015, 9 (06) : VC5 - VC8
  • [8] Placebo-controlled trial of agomelatine in the treatment of major depressive disorder
    Kennedy, SH
    Emsley, R
    [J]. EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2006, 16 (02) : 93 - 100
  • [9] Efficacy and safety of intermittent theta burst stimulation on adolescents and young adults with major depressive disorder: A randomized, double blinded, controlled trial
    Zhang, Min
    Li, Weicheng
    Ye, Yanxiang
    Hu, Zhibo
    Zhou, Yanling
    Ning, Yuping
    [J]. JOURNAL OF AFFECTIVE DISORDERS, 2024, 350 : 214 - 221
  • [10] Efficacy and Safety of Agomelatine vs Paroxetine Hydrochloride in Chinese Han Patients with Major Depressive Disorder A Multicentre, Double-Blind, Noninferiority, Randomized Controlled Trial
    Yu, Yi-Min
    Gao, Ke-Run
    Yu, Hao
    Shen, Yi-Feng
    Li, Hua-Fang
    [J]. JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY, 2018, 38 (03) : 226 - 233
12345